Literature DB >> 4087171

Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.

W R Gillespie, P Veng-Pedersen.   

Abstract

The disposition decomposition approach is employed to derive clearance parameters descriptive of drug distribution kinetics. The name distribution clearance, CLd, is given to a characteristic constant of linear and some nonlinear pharmacokinetic systems. CLd is the clearance associated with the steady-state rate of drug transfer from the peripheral tissues to the systemic circulation. Also introduced is the elimination clearance, CLe, which is associated with the total drug transfer rate from the systemic circulation in linear systems. Estimates of CLd and CLe are presented for several drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087171     DOI: 10.1007/BF01061479

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  31 in total

1.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Pharmacokinetics of cefamandole using a HPLC assay.

Authors:  N S Aziz; J G Gambertoglio; E T Lin; H Grausz; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

3.  Modeling of drug response in individual subjects.

Authors:  A W Kelman; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

4.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

5.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetics of cefroxadin (CGP 9000) in man.

Authors:  A Gerardin; J B Lecaillon; J P Schoeller; G Humbert; J Guibert
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

7.  The pharmacokinetics of furazlocillin in healthy humans.

Authors:  P H Hinderling; U Gundert-Remy; D Förster; W Gau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

8.  Disposition kinetics of ethambutol in man.

Authors:  C S Lee; D C Brater; J G Gambertoglio; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-08

9.  Pharmacokinetics of intravenous isosorbide-dinitrate.

Authors:  R Platzer; G Reutemann; R L Galeazzi
Journal:  J Pharmacokinet Biopharm       Date:  1982-12

10.  Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.

Authors:  J T Burke; W A Wargin; R J Sherertz; K L Sanders; M R Blum; F A Sarubbi
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
View more
  12 in total

Review 1.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

2.  Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

3.  Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA).

Authors:  P Veng-Pedersen; S S Hong; J A Widness; R L Schmidt
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

4.  Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.

Authors:  H Cheng; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

5.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

6.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

7.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

8.  Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework.

Authors:  W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

9.  A technique for calculating the mean time for equilibration of drug distribution using minimal structural assumptions.

Authors:  J M Bailey
Journal:  J Pharmacokinet Biopharm       Date:  1994-04

10.  Drug disposition analysis: a comparison between budesonide and fluticasone.

Authors:  Anders Källén; Lars Thorsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.